Antimicrobial Susceptibility Breakpoints and First-Step parC Mutations in Streptococcus pneumoniae: Redefining Fluoroquinolone Resistance

Clinical antimicrobial susceptibility breakpoints are used to predict the clinical outcome of antimicrobial treatment. In contrast, microbiologic breakpoints are used to identify isolates that may be categorized as susceptible when applying clinical breakpoints but harbor resistance mechanisms that...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Sue, Bast, Darrin, McGeer, Allison, de Azavedo, Joyce, Low, Donald E.
Formato: Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2003
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3023429/
https://www.ncbi.nlm.nih.gov/pubmed/12890324
http://dx.doi.org/10.3201/eid0907.020589

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3023429/
https://www.ncbi.nlm.nih.gov/pubmed/12890324
http://dx.doi.org/10.3201/eid0907.020589

Ejemplares similares